SANTANDER, Oct. 15 (EUROPA PRESS) –
The Ministry of Health and the Cantabrian Health Service (SCS) have invited the population over the age of 60 in Cantabria to vaccinate themselves with the booster dose of COVID-19 and thus to improve their protection against the virus, and also to groups target to approach health centers to get vaccinated against the flu.
The SCS is administering these vaccines. Since last September 26, it has focused on immunizing the sectors of the population most vulnerable to the coronavirus, such as those over the age of 80, people who live or work in nursing homes and other assistance centers for the disabled, and healthcare personnel. .
The new dose of bivalent mRNA vaccines against Covid-19, which is being administered in the current campaign, is adapted to the Omicron variant and can be administered simultaneously with the flu vaccine, the regional executive indicates in a statement.
The SCS is currently noting that the population is receiving more flu vaccinations, refusing in some cases the inoculation of the booster dose against COVID-19, and recalls that the Vaccination Strategy recommends that if it is For those over 60 years, the COVID and influenza vaccines can be given together.
Health centers note an increase in users who refuse to be given the coronavirus vaccine, and evaluating data on the growth of the incidence in other European countries and given the possibility that an epidemic wave could occur in Spain in a few weeks, the Health authorities recommend those over the age of 60 to be vaccinated with the booster dose.
VACCINATION CAMPAIGN
With the data closed yesterday, Friday, 9,145 of the bivalent vaccines against Covid were administered in Cantabria, of which 5,795 administered to those over 80 years old and 3,350 to the population under that age. In the case of those over 80, it represents a vaccination rate of 14 percent.
Since the campaign began on September 26, 4,599 vaccines have been administered in nursing homes. In healthcare professionals 857 doses were administered.
Those over 80 who have had the disease for less than three months and those younger than age should not be vaccinated if they have had COVID in the past 5 months.
To expand the information on the vaccination campaign, the SCS has enabled a space on its website where it will permanently update the information in this regard: https://www.scsalud.es/coronavirus-vacunas-ciudadanos.
Furthermore, the Ministry and the SCS encourage all people included in the target groups to get vaccinated against influenza because it is essential to protect the vulnerable population from this seasonal disease.
Against the flu, the vaccine was administered in Cantabria to 20,522 people, mainly in the age group between 60 and 80 years.
As in previous years, the flu vaccine is recommended for people over the age of 60 and for those between 6 months and 59 years old who belong to one of the risk groups for serious flu complications, such as people with chronic cardiovascular disease. (excluding isolated arterial hypertension) or respiratory, including bronchopulmonary dysplasia, cystic fibrosis, or asthma.
Vaccination is also recommended for children over 6 months of age and adults with metabolic diseases (including diabetes mellitus), morbid obesity, renal failure, hemoglobinopathies and anemia, asplenia, chronic liver disease, severe neurological and neuromuscular diseases, drug-induced immunosuppression, transplants or HIV-positive people, cancer, cerebrospinal fluid fistula, celiac disease, inflammatory bowel disease, cochlear or pregnant implantation, or disorders and diseases that lead to cognitive dysfunction such as Down syndrome or dementia.
Vaccination is also indicated in pregnant women in any trimester of pregnancy, as well as in children and adolescents who receive prolonged treatment with acetylsalicylic acid, due to the possibility of developing Reye’s syndrome after the flu.
The Government also recommends the vaccine in people who, due to their activity, can transmit the flu to those who have a high risk of presenting complications, and recalls the importance of the mask as a mechanism for preventing contagion against viral diseases of respiratory transmission. .
